Evidence map›Paper›PMID 10917542›Full record

ArticleBritish journal of cancer2000

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor.

D Albo, V L Rothman, D D Roberts, G P Tuszynski

Open access · hybridAbstract read
In one paragraph

Article in British journal of cancer, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Expression of thrombospondin-1 in conjunctival squamous cell carcinoma is correlated to the Ki67 index and associated with progression-free survival.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2021
    Article
  3. Article
  4. Article
  5. THBS1 facilitates colorectal liver metastasis through enhancing epithelial-mesenchymal transition.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion.Laboratory investigation; a journal of technical methods and pathology · 2014
    Review
  12. Article
  13. Article
  14. Article
  15. The effect of thrombospondin-1 on breast cancer metastasis.Breast cancer research and treatment · 2009
    Article
  16. Article
  17. Article
  18. Article
  19. High Expression ofTechnology in cancer research & treatment
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

D AlboDepartment of Surgery, MCP Hahnemann University, Philadelphia, PA 19102, USA.
V L Rothman
D D Roberts
G P Tuszynski
Hahnemann University Hospital · USNational Cancer Institute · US

Funding

CELLULAR INTERACTIONS WITH THROMBOSPONDINZ01SC009172 · SC · DIVISION OF CLINICAL SCIENCES - NCI · PI ROBERTS, DAVID D · 1996 to 2008
$1.7M
CSVTCG-SPECIFIC THROMBOSPONDIN RECEPTOR IN BREAST CANCERR01CA065675 · NCI · MCP HAHNEMANN UNIVERSITY · PI TUSZYNSKI, GEORGE PAUL · 1995 to 1997
–
THROMBOSPONDIN IN BREAST CANCER INVASION &ANGIOGENESISR01CA069722 · NCI · ALLEGHENY UNIVERSITY OF HEALTH SCIENCES · PI TUSZYNSKI, GEORGE PAUL · 1995 to 1996
–
NCI NIH HHS CA65675NCI NIH HHS CA69722
6 · The paper itself

Abstract

We have previously shown that platelet-produced thrombospondin-1 up-regulates the urokinase plasminogen activator and its receptor and promotes tumour cell invasion. Although tumour cells produce thrombospondin-1 in vivo, they produce only minimal amounts of thrombospondin-1 in vitro. To determine the effect of tumour cell-produced thrombospondin-1 in the regulation of the plasminogen/plasmin system and tumour cell invasion, we studied THBS-1-transfected MDA-MB-435 breast cancer cells that overexpress thrombospondin-1. The role of urokinase plasminogen receptor in thrombospondin-1-mediated adhesion and invasion was studied by antisense inhibition, enzymatic cleavage and antibody neutralization. Tumour cell adhesion to collagen and laminin was evaluated. Tumour cell invasion was studied in a modified Boyden chamber collagen invasion assay. Tumour cell thrombospondin-1 induced a 2-7 fold increase in urokinase plasminogen activator receptor and cell-associated urokinase plasminogen activator expression and a 50-65% increase in cell-associated urokinase plasminogen activator and plasmin activities. Furthermore, tumour cell thrombospondin-1 promoted tumour cell invasion and decreased tumour cell adhesion through up-regulation of urokinase plasminogen activator receptor-controlled urokinase plasminogen activator and plasmin activities. We conclude that tumour cell-produced thrombospondin-1 may play a critical role in the regulation of tumour cell adhesion and tumour cell invasion.

Indexed as

Blotting, WesternBreast NeoplasmsCell AdhesionEnzyme-Linked Immunosorbent AssayFibrinolysinGene Expression Regulation, NeoplasticHumansNeoplasm InvasivenessPlasminogenReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorThrombospondin 1TransfectionTransforming Growth Factor betaTumor Cells, CulturedUp-RegulationFibrinolysinPlasminogenPLAUR protein, humanReceptors, Cell SurfaceReceptors, Urokinase Plasminogen ActivatorThrombospondin 1Transforming Growth Factor betaUrokinase-Type Plasminogen Activator

Identifiers

PMID10917542
PMCPMC2374573
OpenAlexW1750572319

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.